Larimar Therapeutics

$17.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-1.82%) As of 6:15 PM UTC today

Why Robinhood?

You can buy or sell LRMR and other stocks, options, and ETFs commission-free!

About LRMR

Larimar Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia. The company was founded on May 29, 2020 and is headquartered in Bala Cynwyd, PA. The listed name for LRMR is Larimar Therapeutics, Inc. Common Stock.

CEO

Carole S. Ben-Maimon

Employees

Headquarters

Bala Cynwyd, Pennsylvania

Founded

2020

Market Cap

261.07M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

81.99K

High Today

$17.51

Low Today

$17.13

Open Price

$17.43

Volume

18.77K

52 Week High

$25.87

52 Week Low

$7.43

LRMR Earnings

-$1.21

-$0.81

-$0.40

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, Pre-Market